Publications by authors named "K Miquel"

Claim this Profile
T
The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
Thierry Lefèvre, John Ormiston, Giulio Guagliumi, Heinz-Peter Schultheiss, Laurent Quilliet, Karin Miquel

J Am Coll Cardiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
Patrick W Serruys, John A Ormiston, Georgios Sianos, J Eduardo Sousa, Eberhard Grube, Karine Miquel

J Am Coll Cardiol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068.
G P Prevost, A Pradines, I Viossat, M C Brezak, K Miquel

Int J Cancer· October 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells.
K Miquel, A Pradines, F Tercé, S Selmi, G Favre

J Biol Chem· October 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells.
K Miquel, A Pradines, J Sun, Y Qian, A D Hamilton

Cancer Res· May 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis